Target intelligence / Profile preview

Lysosomal and endosomal compartments of antigen-presenting cells

Molecular classification
Other
01

Overview

The lysosomal and endosomal compartments of antigen-presenting cells (APCs) are specialized acidic organelles, including early endosomes, late endosomes, and lysosomes, that play a central role in the processing and presentation of exogenous antigens (Roche & Furuta, 2015). These compartments facilitate the degradation of internalized proteins into peptides through the action of acid-dependent proteases, such as cathepsins, which are optimally active at low pH (Schrezenmeier & Dörner, 2020). In the MHC class II compartment (MIIC), these peptides are loaded onto MHC class II molecules for subsequent display on the cell surface to CD4+ T cells, a process essential for initiating adaptive immune responses (Roche & Furuta, 2015). Furthermore, these compartments house endosomal Toll-like receptors (TLRs 7, 8, and 9) that recognize nucleic acids, serving as critical sensors for viral and bacterial pathogens as well as self-nucleic acids in autoimmune contexts (Kuznik et al., 2011). Pharmacological agents like hydroxychloroquine and chloroquine are weak bases that accumulate within these acidic vesicles, increasing the internal pH and thereby inhibiting protease activity and TLR signaling (Schrezenmeier & Dörner, 2020). This interference reduces the presentation of self-antigens and the production of pro-inflammatory cytokines, making these compartments a significant site of action for treating systemic lupus erythematosus and rheumatoid arthritis (Kuznik et al., 2011).

Other names
Endolysosomal systemMHC class II compartment (MIIC)Endocytic pathwayLysosomal-endosomal system
02

Mechanism of action

Inhibition of endosomal acidification and lysosomal protease activity, leading to impaired antigen processing and reduced Toll-like receptor signaling (Schrezenmeier & Dörner, 2020).

03

Biological functions

Antigen processingAntigen presentationEndocytosisProteolysisToll-like receptor signalingImmune response
04

Disease associations

Systemic lupus erythematosusRheumatoid arthritisInfectionAutoimmune diseaseInflammation
05

Safety considerations

RetinopathyQT interval prolongationCardiotoxicityNeuromuscular toxicity
06

Interacting drugs

Hydroxychloroquine

1 more in the full profile.

07

Biomarkers

Lysosomal pHCathepsin activity levelsMHC class II surface expression

Beyond the preview

Go deeper on Lysosomal and endosomal compartments of antigen-presenting cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysosomal and endosomal compartments of antigen-presenting cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call